The Clorox Company

Q2 FY26Household Products

The Clorox Company Q2 FY26 Results — Earnings Call Analysis

Q2 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹96

Market cap₹11.6K Cr

P/E15.6

Updated30 May 2026

Read4 min read

What the Q2 FY26 call signalled

1 of 3 strong

RevenueRank 4

MarginRank 4

CapexYes

Not discussed on this call: fundraise, order book.

The short version

- Growth momentum is seen in several portfolio areas, including cleaning, Glad, and International businesses. - The acquired GOJO business (approx. - The company expects to continue making progress in innovation, which is a significant driver for top-line growth and market share gains through fiscal year ’27 and beyond.

From The Clorox Company's Q2 FY26 earnings-call transcript · updated 30 May 2026.

Revenue & Sales Performance

Rank 4

Growth momentum is seen in several portfolio areas, including cleaning, Glad, and International businesses.
The acquired GOJO business (approx. $800 million) is growing mid-single digits and contributing roughly 3% growth for the full year with further additions expected in fiscal 2027.
Total Distribution Points (TDPs) are up over 5%, indicating increased shelf space and distribution.
Innovation and on-shelf presence improvements are focused on driving growth, particularly in categories like Litter (multi-year reinvention underway) and Food (returning to share growth).
Challenges remain in some categories like Litter and Food, which showed slower improvements than expected but are targeted for recovery through price pack architecture and innovation.
Management expects continued progress in Q4 and fiscal 2027 with a strengthening pipeline of cost savings and revenue growth initiatives.
Overall, the strategy aims to accelerate share gains and improved execution for stronger sales and volume growth in fiscal 2027.

Profitability & Margins

The company expects to continue making progress in innovation, which is a significant driver for top-line growth and market share gains through fiscal year ’27 and beyond.
Cost-saving initiatives, including accelerating structural cost savings planned for 2028 into 2027, aim to mitigate input cost pressures and support margin improvement.
The GOJO acquisition causes an initial gross margin dilution (about 50 basis points ongoing, with one-time 150 basis points headwind in Q4), but synergies and supply chain efficiencies are expected to improve margins over time.
Elevated input costs due to geopolitical issues (e.g., Middle East conflict) pose short-term margin headwinds, but the company has tools to manage inflationary pressures while maintaining value for consumers.
ERP stabilization costs affected margins in H1 and Q3 but are expected to normalize with minimal impact in Q4 and beyond.
Overall, operating earnings and EPS growth will be supported by innovation, cost management, and margin recovery, despite near-term inflationary and operational headwinds.

See what The Clorox Company said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes

A significant supply chain project is being accelerated as a strategic investment to deliver substantial cost savings starting fiscal year 2027. This acceleration required upfront investment in the current quarter, including possible asset write-offs and engineering costs (Page 15).
The company is investing in innovation across the portfolio and strengthening plans to accelerate share gains heading into fiscal 2027, which may include increased advertising and promotional spending (Pages 15, 10).
There is an emphasis on making advertising and sales promotion spending more efficient by leveraging data, technology, and AI to improve return on investment, primarily to drive value superiority in brands including Glad (Page 10).
Some structural cost-saving initiatives planned for later years are being accelerated into fiscal 2027, supported by one-time investments recognized in the current fiscal quarter (Page 4, 15).

Top-ranked in Household Products

Ranked on what management guided this quarter

5x potential

1Jyothy Labs₹7.2K Cr

Rev 3Mar 2

2DOMS Industries₹12.9K Cr

Rev 3Mar 3

3₹2.6K Cr

Rev 3Mar 3

4₹2.5K Cr

Rev 3Mar 3

5₹569 Cr

Rev 4Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The transcript does not mention any current or planned new fundraising through debt or equity.
There is no discussion of issuing new shares, raising capital, or taking on additional debt.
The focus is primarily on operational improvements, cost-saving investments, and managing cost pressures.
Investments mentioned are related to accelerating supply chain projects and structural cost savings rather than raising external funds.
The company is actively managing margins, pricing, advertising, and portfolio optimization without indicating external fundraising needs.

See what The Clorox Company said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided document does not explicitly mention "Current/ Expected Orderbook" or "Pending Orders." However, key related points include: - Distribution points (TDPs) are up over 5% in Q3, indicating increased product availability. - Shelf space gains are progressing according to plan at an aggregate level. - Some difficulties remain in shelf placement, particularly in the Litter category, but adjustments are ongoing. - Advertising and promotional activities are being aligned with product distribution to improve sales velocity. - The company is investing in price pack architecture and revenue growth management (RGM) levers to optimize pricing and value. - There is no specific mention or quantification of order backlog or pending orders in the text provided. If you are seeking detailed orderbook or pending order figures, they are not disclosed in the sections provided.

Others in Household Products this season

Church & Dwight Co., Inc. (Q2 FY26)
Church & Dwight Co., Inc. Q2 FY26 quarterly results analysis. Full year 2026 organic sales growth expected at approximately 3% to 4%. Market Cap $23,133, P/E 31
Kimberly-Clark Corporation (Q2 FY26)
Kimberly-Clark Corporation Q2 FY26 quarterly results analysis. Strong start to 2026 with 2.5% organic growth in Q1; volume plus mix growth up 3%, marking ninth

Compare:vs Kimberly-Clark Corporation vs Church & Dwight Co., Inc.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were The Clorox Company Q2 FY26 results?

What is The Clorox Company share price analysis?

The Clorox Company currently shows a neutral. The stock trades at a P/E of 15.6 with a market cap of $11,633. Investors should review the full earnings analysis for detailed insights.

Is The Clorox Company planning capital expenditure?

- A significant supply chain project is being accelerated as a strategic investment to deliver substantial cost savings starting fiscal year 2027.

Keep The Clorox Company on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

What the Q2 FY26 call signalled

Revenue & Sales Performance

Profitability & Margins

Capital Expenditure Plans

Top-ranked in Household Products

Fundraising & Capital Structure

Order Book & Pipeline

Continue your research

Others in Household Products this season

Frequently Asked Questions